ArticleARYA atherosclerosis2015

The effect of pioglitazone on circulating interleukin-10 and tumor necrosis factor-alpha levels in a patient with metabolic syndrome: A randomized, double-blind controlled trial.

Ali Pourmoghaddas et al.PubMed ↗Full text ↗

No numbers read from the abstract.